Cite
APA Citation
Kashyap, A. S., Thelemann, T., Klar, R., Kallert, S. M., Festag, J., Buchi, M., Hinterwimmer, L., Schell, M., Michel, S., Jaschinski, F., & Zippelius, A. (2019). antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity. Journal for immunotherapy of cancer, 7(1), . http://access.bl.uk/ark:/81055/vdc_100144514844.0x00001f